1967 - 1968年纯化系统中纤溶酶、纤溶酶原和尿激酶的检测方法及标准制剂 - Suppr

Suppr

超能文献

Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968.

作者信息

Johnson A J, Kline D L, Alkjaersig N

出版信息

Thromb Diath Haemorrh. 1969 Apr 30;21(2):259-72.

PMID:4238780

Abstract

摘要

相似文献

Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968.1967 - 1968年纯化系统中纤溶酶、纤溶酶原和尿激酶的检测方法及标准制剂

Thromb Diath Haemorrh. 1969 Apr 30;21(2):259-72.

Report of the Subcommittee on Fibrinolysis and Thrombolysis.

Thromb Diath Haemorrh Suppl. 1967;26:457-9.

[A quick photometric method for the determination of activable plasminogen and of plasmin].一种用于测定可激活纤溶酶原和纤溶酶的快速光度法。

Thromb Diath Haemorrh. 1967 May 31;17(3-4):452-66.

Plasmin potency estimates: influence of the substrate used in assay.

Thromb Haemost. 1981 Apr 30;45(2):107-9.

Fibrinolytic standards and assay methods--1967-1968.

Thromb Diath Haemorrh Suppl. 1968;35:185-7.

The plasminogen content of commercial preparations and of normal donor plasma in relation to the plasmin content of the 1st international plasmin reference preparation.

Thromb Haemost. 1979 Aug 31;42(2):582-95.

Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.基于溶解时间法的纤溶酶原和尿激酶测定。底物的纯化——动力学和方法学研究。

Acta Med Scand Suppl. 1967;478:1-45.

Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.标准链激酶和纤溶酶制剂检测中的变异：纤溶酶、纤溶酶原和纤维蛋白原变异性的证据及影响

Fed Proc. 1966 Jan-Feb;25(1):34-41.

Assay of the antifibrinolytic activity in human plasma by means of the lysis time method.

Thromb Diath Haemorrh. 1968 Dec 31;20(3):561-73.

A study of proteolytic and fibrinolytic factors in the human prostate.

Thromb Diath Haemorrh. 1971 Jun 30;25(3):481-98.

引用本文的文献

New protein hydrolysates from collagen wastes used as peptone for bacterial growth.来自胶原蛋白废料的新型蛋白质水解物用作细菌生长的蛋白胨。

Curr Microbiol. 2007 Jan;54(1):54-7. doi: 10.1007/s00284-006-0308-y. Epub 2006 Dec 13.

Recurring thrombo-embolic accidents caused by family-related deficiency of the fibrinolysis system.由家族性纤维蛋白溶解系统缺陷引起的复发性血栓栓塞事件。

Blut. 1980 Dec;41(6):437-44. doi: 10.1007/BF01007768.

Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.交联纤维蛋白的血浆降解。新型大分子可溶性复合物的表征及其结构模型。

J Clin Invest. 1980 Nov;66(5):1033-43. doi: 10.1172/JCI109931.

Partial purification and properties of a plasminogen activator from human erythrocytes.人红细胞纤溶酶原激活剂的部分纯化及性质

J Clin Invest. 1969 Oct;48(10):1777-85. doi: 10.1172/JCI106144.

Clinical experience with brinase.布瑞纳酶的临床经验。

J Clin Pathol. 1972 Jul;25(7):654-5. doi: 10.1136/jcp.25.7.654.

Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.犬对单次注射尿激酶和伤寒疫苗以及血管损伤的纤溶酶原 - 125I反应。

J Clin Invest. 1972 Jun;51(6):1363-77. doi: 10.1172/JCI106932.

Standardization of diagnostic materials. 3. Laboratory reagents and coagulation assay procedures.诊断材料的标准化。3. 实验室试剂与凝血检测程序。

Bull World Health Organ. 1973 Jun;48(6):727-36.

Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.不同给药方案的肝素和链激酶对实验性肺栓塞的溶解作用。

J Clin Invest. 1974 Oct;54(4):782-91. doi: 10.1172/JCI107818.

Discrepancies between immunological and caseinolytic plasma plasminogen assays in health and hyperfibrinolytic states.健康及高纤溶状态下免疫法与酪蛋白溶解血浆纤溶酶原检测结果的差异。

J Clin Pathol. 1974 Oct;27(10):794-7. doi: 10.1136/jcp.27.10.794.

Structural changes accompanying enzymatic activation of human Hageman factor.伴随人哈格曼因子酶促激活的结构变化

J Clin Invest. 1974 Sep;54(3):619-27. doi: 10.1172/JCI107799.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验